{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:20:26Z","timestamp":1761920426975,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013726","name":"Abraham J. & Phyllis Katz Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013726","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.preghy.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T19:48:00Z","timestamp":1519501680000},"page":"40-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Villous explants from preeclamptic placentas induce sFlt1 in PBMCs: An ex vivo co-culture study"],"prefix":"10.1016","volume":"12","author":[{"given":"Stephen Kyle","family":"Gonzales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Badell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanh","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-9212","authenticated-orcid":false,"given":"Bassam","family":"Rimawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkataraman","family":"Deepak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Sidell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.preghy.2018.02.006_b0005","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US preventive services task force recommendation statement","volume":"317","author":"Force","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.preghy.2018.02.006_b0010","doi-asserted-by":"crossref","first-page":"e0160808","DOI":"10.1371\/journal.pone.0160808","article-title":"Systematic review of micro-RNA expression in pre-eclampsia identifies a number of common pathways associated with the disease","volume":"11","author":"Sheikh","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.preghy.2018.02.006_b0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2018.02.006_b0020","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1186\/1752-1947-3-7311","article-title":"Transient early preeclampsia in twin pregnancy with a triploid fetus: a case report","volume":"3","author":"van der Houwen","year":"2009","journal-title":"J. Med. Case Rep."},{"issue":"3","key":"10.1016\/j.preghy.2018.02.006_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ackd.2013.02.003","article-title":"New developments in the pathogenesis of preeclampsia","volume":"20","author":"Naljayan","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"1","key":"10.1016\/j.preghy.2018.02.006_b0030","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/JOE-16-0340","article-title":"Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia","volume":"232","author":"Boeldt","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.preghy.2018.02.006_b0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.placenta.2017.06.005","article-title":"Emerging role for dysregulated decidualization in the genesis of preeclampsia","volume":"60","author":"Conrad","year":"2017","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/10641955.2017.1299172","article-title":"Human endometrial stromal cell plasticity: reversible sFlt1 expression negatively coincides with decidualization","volume":"36","author":"Cottrell","year":"2017","journal-title":"Hypertens. Pregnancy"},{"issue":"40","key":"10.1016\/j.preghy.2018.02.006_b0045","doi-asserted-by":"crossref","first-page":"E8468","DOI":"10.1073\/pnas.1706546114","article-title":"Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology","volume":"114","author":"Garrido-Gomez","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.preghy.2018.02.006_b0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1600-0897.2010.00831.x","article-title":"Immunology of pre-eclampsia","volume":"63","author":"Redman","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.preghy.2018.02.006_b0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.preghy.2018.02.006_b0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.preghy.2018.02.006_b0065","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.preghy.2018.02.006_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"1","key":"10.1016\/j.preghy.2018.02.006_b0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2008.10.006","article-title":"Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women","volume":"30","author":"Rajakumar","year":"2009","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.preghy.2018.02.006_b0080","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2018.02.006_b0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/mend.13.4.0265","article-title":"Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity","volume":"13","author":"He","year":"1999","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"10.1016\/j.preghy.2018.02.006_b0090","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.placenta.2013.09.016","article-title":"Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy","volume":"34","author":"Zamudio","year":"2013","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.preghy.2018.02.006_b0095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.preghy.2018.02.006_b0100","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.preghy.2018.02.006_b0105","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","volume":"95","author":"Ahmad","year":"2004","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.preghy.2018.02.006_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.01.024","article-title":"Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia","volume":"210","author":"Major","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.preghy.2018.02.006_b0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.placenta.2004.09.001","article-title":"Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women","volume":"26","author":"Rajakumar","year":"2005","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.preghy.2018.02.006_b0120","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1","volume":"71","author":"Makris","year":"2007","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.preghy.2018.02.006_b0125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1008377921886","article-title":"Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?","volume":"10","author":"Wynendaele","year":"1999","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1155\/2011\/535109","article-title":"Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts","volume":"31","author":"Starlinger","year":"2011","journal-title":"Dis. Markers"},{"key":"10.1016\/j.preghy.2018.02.006_b0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jri.2016.06.009","article-title":"Maternal monocytes in pregnancy and preeclampsia in humans and in rats","volume":"119","author":"Faas","year":"2017","journal-title":"J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.preghy.2018.02.006_b0140","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","author":"American College of, O., Gynecologists, and P. Task Force on Hypertension","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10641955.2016.1259627","article-title":"Relationship between hypoxia and downstream pathogenic pathways in preeclampsia","volume":"36","author":"Korkes","year":"2017","journal-title":"Hypertens. Pregnancy"},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.111.182170","article-title":"Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"59","author":"Rajakumar","year":"2012","journal-title":"Hypertension"},{"issue":"5 Pt 2","key":"10.1016\/j.preghy.2018.02.006_b0155","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"Maynard","year":"2005","journal-title":"Pediatr. Res."},{"issue":"8","key":"10.1016\/j.preghy.2018.02.006_b0160","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/14767050903366119","article-title":"Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice","volume":"23","author":"Ogge","year":"2010","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1095\/biolreprod.113.115592","article-title":"Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy","volume":"90","author":"Zamudio","year":"2014","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/172460080101600202","article-title":"Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments","volume":"16","author":"Dittadi","year":"2001","journal-title":"Int. J. Biol. Markers"},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0175","doi-asserted-by":"crossref","first-page":"e56754","DOI":"10.1371\/journal.pone.0056754","article-title":"Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin","volume":"8","author":"Tannetta","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.preghy.2018.02.006_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.preghy.2018.02.006_b0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753944708094227","article-title":"Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?","volume":"2","author":"Craici","year":"2008","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.preghy.2018.02.006_b0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/heartjnl-2016-309671","article-title":"Recurrent pre-eclampsia and subsequent cardiovascular risk","volume":"103","author":"Auger","year":"2017","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.preghy.2018.02.006_b0195","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2014.02.529","article-title":"Pre-eclampsia and future cardiovascular risk among women: a review","volume":"63","author":"Ahmed","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.preghy.2018.02.006_b0200","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/HYPERTENSIONAHA.116.07371","article-title":"Suppressed production of soluble fms-like tyrosine kinase-1 contributes to myocardial remodeling and heart failure","volume":"68","author":"Seno","year":"2016","journal-title":"Hypertension"},{"issue":"24","key":"10.1016\/j.preghy.2018.02.006_b0205","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/CIRCULATIONAHA.109.867929","article-title":"Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis","volume":"120","author":"Onoue","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.preghy.2018.02.006_b0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ki.2013.402","article-title":"Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease","volume":"85","author":"Luft","year":"2014","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.preghy.2018.02.006_b0215","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.preghy.2018.02.006_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2006.02.004","article-title":"Georg Schmorl on trophoblasts in the maternal circulation","volume":"28","author":"Lapaire","year":"2007","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.preghy.2018.02.006_b0225","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1161\/HYPERTENSIONAHA.113.01505","article-title":"Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung","volume":"62","author":"Buurma","year":"2013","journal-title":"Hypertension"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:51:17Z","timestamp":1761897077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778917304932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":45,"alternative-id":["S2210778917304932"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2018.02.006","relation":{},"ISSN":["2210-7789"],"issn-type":[{"type":"print","value":"2210-7789"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Villous explants from preeclamptic placentas induce sFlt1 in PBMCs: An ex vivo co-culture study","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}